Foghorn Therapeutics Inc Capital Reinvestment Ratio
Foghorn Therapeutics Inc capital reinvestment ratio. Foghorn Therapeutics Inc (FHTX) has a Capital Reinvestment Ratio of 0.00x as of March 2022, meaning it reinvests 0% of its operating cash flow ($271.53 Million) in capital expenditures ($247.00K). Check total reinvestment intensity of Foghorn Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Foghorn Therapeutics Inc (2022–2022)
Capital reinvestment ratio of Foghorn Therapeutics Inc from 2022 to 2022. This chart tracks Foghorn Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore how fast is Foghorn Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Foghorn Therapeutics Inc Capital Reinvestment Ratio by Year (2022–2022)
Foghorn Therapeutics Inc capital reinvestment ratio by year from 2022 to 2022. For the full cash flow conversion analysis, see Foghorn Therapeutics Inc cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.01x | $193.61 Million | $1.21 Million | — |